A reiter-szindroma

Translated title of the contribution: Reiter-syndrome

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The Reiter-syndrome is the complex of sterile arthritis, urethritis and conjunctivitis and involvement of other organs (skin, mucosal membranes, cardiac conducting system) following bacterial enteric or urogenital infection. Systemic signs can also occur with polyarthritis. This syndrome belongs to the reactive arthritis group. In each year there are 3040 new cases among 100 000 citizens. The disease can occur at any age, but most of the patients are 20-40 years old. It is the patient's genetic background and the type of invading microbes that play a leading role in the pathomechanism of the disease. The exact pathomechanism is yet unknown, therefore our treatment is symptomatic. It is advised to immobilize the involved joint and aspirate the excess fluid and to take non-steroidal antiinflammatory drugs. The patient's medical history is most important to diagnose the disease, because laboratory tests may show signs of inflammation, the serology can only prove antecedent infection, viable organism can not be cultured from the involved organs and the imaging procedures and histology shows non-specific inflammation only. The importance of diagnostic procedures is to exclude the presence of other diseases. Other causes of monarticular inflammation (infection, crystal induced arthritis, sarcoid arthritis) and rheumatic fever should be excluded. The disease lasts for 3-6 months. 2 to 18% of the patients develop chronic arthritis and 12 to 26% of the patients develop ankylosing spondylitis.

Original languageHungarian
Pages (from-to)405-410
Number of pages6
JournalLege Artis Medicinae
Volume10
Issue number5
Publication statusPublished - 2000

Fingerprint

Reactive Arthritis
Arthritis
Inflammation
Infection
Urethritis
Conjunctivitis
Rheumatic Fever
Ankylosing Spondylitis
Serology
Histology
Anti-Inflammatory Agents
Joints
Skin
Membranes
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A reiter-szindroma. / Géher, P.

In: Lege Artis Medicinae, Vol. 10, No. 5, 2000, p. 405-410.

Research output: Contribution to journalArticle

Géher, P 2000, 'A reiter-szindroma', Lege Artis Medicinae, vol. 10, no. 5, pp. 405-410.
Géher, P. / A reiter-szindroma. In: Lege Artis Medicinae. 2000 ; Vol. 10, No. 5. pp. 405-410.
@article{304f45d70d0840f1bdce244b1756d4df,
title = "A reiter-szindroma",
abstract = "The Reiter-syndrome is the complex of sterile arthritis, urethritis and conjunctivitis and involvement of other organs (skin, mucosal membranes, cardiac conducting system) following bacterial enteric or urogenital infection. Systemic signs can also occur with polyarthritis. This syndrome belongs to the reactive arthritis group. In each year there are 3040 new cases among 100 000 citizens. The disease can occur at any age, but most of the patients are 20-40 years old. It is the patient's genetic background and the type of invading microbes that play a leading role in the pathomechanism of the disease. The exact pathomechanism is yet unknown, therefore our treatment is symptomatic. It is advised to immobilize the involved joint and aspirate the excess fluid and to take non-steroidal antiinflammatory drugs. The patient's medical history is most important to diagnose the disease, because laboratory tests may show signs of inflammation, the serology can only prove antecedent infection, viable organism can not be cultured from the involved organs and the imaging procedures and histology shows non-specific inflammation only. The importance of diagnostic procedures is to exclude the presence of other diseases. Other causes of monarticular inflammation (infection, crystal induced arthritis, sarcoid arthritis) and rheumatic fever should be excluded. The disease lasts for 3-6 months. 2 to 18{\%} of the patients develop chronic arthritis and 12 to 26{\%} of the patients develop ankylosing spondylitis.",
keywords = "Epidemiology, Pathogenesis, Reactive arthritis, Reiter-syndrome, Seronegative spondylarthritis, Therapy",
author = "P. G{\'e}her",
year = "2000",
language = "Hungarian",
volume = "10",
pages = "405--410",
journal = "Lege Artis Medicinae",
issn = "0866-4811",
publisher = "Literatura Medica Publishing House",
number = "5",

}

TY - JOUR

T1 - A reiter-szindroma

AU - Géher, P.

PY - 2000

Y1 - 2000

N2 - The Reiter-syndrome is the complex of sterile arthritis, urethritis and conjunctivitis and involvement of other organs (skin, mucosal membranes, cardiac conducting system) following bacterial enteric or urogenital infection. Systemic signs can also occur with polyarthritis. This syndrome belongs to the reactive arthritis group. In each year there are 3040 new cases among 100 000 citizens. The disease can occur at any age, but most of the patients are 20-40 years old. It is the patient's genetic background and the type of invading microbes that play a leading role in the pathomechanism of the disease. The exact pathomechanism is yet unknown, therefore our treatment is symptomatic. It is advised to immobilize the involved joint and aspirate the excess fluid and to take non-steroidal antiinflammatory drugs. The patient's medical history is most important to diagnose the disease, because laboratory tests may show signs of inflammation, the serology can only prove antecedent infection, viable organism can not be cultured from the involved organs and the imaging procedures and histology shows non-specific inflammation only. The importance of diagnostic procedures is to exclude the presence of other diseases. Other causes of monarticular inflammation (infection, crystal induced arthritis, sarcoid arthritis) and rheumatic fever should be excluded. The disease lasts for 3-6 months. 2 to 18% of the patients develop chronic arthritis and 12 to 26% of the patients develop ankylosing spondylitis.

AB - The Reiter-syndrome is the complex of sterile arthritis, urethritis and conjunctivitis and involvement of other organs (skin, mucosal membranes, cardiac conducting system) following bacterial enteric or urogenital infection. Systemic signs can also occur with polyarthritis. This syndrome belongs to the reactive arthritis group. In each year there are 3040 new cases among 100 000 citizens. The disease can occur at any age, but most of the patients are 20-40 years old. It is the patient's genetic background and the type of invading microbes that play a leading role in the pathomechanism of the disease. The exact pathomechanism is yet unknown, therefore our treatment is symptomatic. It is advised to immobilize the involved joint and aspirate the excess fluid and to take non-steroidal antiinflammatory drugs. The patient's medical history is most important to diagnose the disease, because laboratory tests may show signs of inflammation, the serology can only prove antecedent infection, viable organism can not be cultured from the involved organs and the imaging procedures and histology shows non-specific inflammation only. The importance of diagnostic procedures is to exclude the presence of other diseases. Other causes of monarticular inflammation (infection, crystal induced arthritis, sarcoid arthritis) and rheumatic fever should be excluded. The disease lasts for 3-6 months. 2 to 18% of the patients develop chronic arthritis and 12 to 26% of the patients develop ankylosing spondylitis.

KW - Epidemiology

KW - Pathogenesis

KW - Reactive arthritis

KW - Reiter-syndrome

KW - Seronegative spondylarthritis

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=0033948375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033948375&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 405

EP - 410

JO - Lege Artis Medicinae

JF - Lege Artis Medicinae

SN - 0866-4811

IS - 5

ER -